Clustering O
of O
missense O
mutations O
in O
the O
ataxia B
- I
telangiectasia I
gene O
in O
a O
sporadic B
T I
- I
cell I
leukaemia I
. O

Ataxia B
- I
telangiectasia I
( O
A B
- I
T I
) O
is O
a O
recessive B
multi I
- I
system I
disorder I
caused O
by O
mutations O
in O
the O
ATM O
gene O
at O
11q22 O
- O
q23 O
( O
ref O
. O
3 O
) O
. O

By O
analysing O
tumour B
DNA O
from O
patients O
with O
sporadic B
T I
- I
cell I
prolymphocytic I
leukaemia I
( O
T B
- I
PLL I
) O
, O
a O
rare O
clonal B
malignancy I
with O
similarities O
to O
a O
mature B
T I
- I
cell I
leukaemia I
seen O
in O
A B
- I
T I
, O
we O
demonstrate O
a O
high O
frequency O
of O
ATM O
mutations O
in O
T B
- I
PLL I
. O

Autosomal B
dominant I
neurohypophyseal I
diabetes I
insipidus I
( O
ADNDI B
) O
is O
an O
inherited B
disease I
caused O
by O
progressive O
degeneration O
of O
the O
magnocellular O
neurons O
of O
the O
hypothalamus O
leading O
to O
decreased O
ability O
to O
produce O
the O
hormone O
arginine O
vasopressin O
( O
AVP O
) O
. O

Mucopolysaccharidosis B
IVA I
( O
MPS B
IVA I
) O
is O
an O
autosomal B
recessive I
lysosomal I
storage I
disorder I
caused O
by O
a O
genetic B
defect I
in O
N O
- O
acetylgalactosamine O
- O
6 O
- O
sulfate O
sulfatase O
( O
GALNS O
) O
. O

A O
nonsense O
mutation O
in O
exon O
17 O
( O
codon O
556 O
) O
of O
the O
RB1 O
gene O
was O
found O
to O
be O
present O
homozygously O
in O
both O
the O
retinal B
and I
the I
pineal I
tumours I
. O

The O
von B
Hippel I
- I
Lindau I
tumor I
suppressor O
gene O
is O
required O
for O
cell O
cycle O
exit O
upon O
serum O
withdrawal O
. O

Conversely O
, O
the O
majority O
of O
families O
with O
male B
and I
female I
breast I
cancer I
were O
due O
to O
BRCA2 O
( O
76 O
% O
) O
. O

We O
compared O
horizontal O
eye O
movements O
( O
visually O
guided O
saccades O
, O
antisaccades O
, O
and O
smooth O
pursuit O
) O
in O
control O
subjects O
( O
n O
= O
14 O
) O
and O
patients O
with O
three O
forms O
of O
autosomal O
dominant O
cerebellar B
ataxias I
type I
I I
spinocerebellar B
ataxias I
1 I
and I
2 I
( O
SCA1 B
, O
n O
= O
11 O
; O
SCA2 B
, O
n O
= O
10 O
) O
and O
SCA3 B
/ O
Machado B
- I
Joseph I
disease I
( O
MJD B
) O
( O
n O
= O
16 O
) O
. O

Mucopolysaccharidosis B
IVA I
( O
MPS B
IVA I
) O
is O
an O
autosomal B
recessive I
lysosomal I
storage I
disorder I
caused O
by O
a O
genetic B
defect I
in O
N O
- O
acetylgalactosamine O
- O
6 O
- O
sulfate O
sulfatase O
( O
GALNS O
) O
. O

The O
185delAG O
mutation O
in O
BRCA1 O
is O
detected O
in O
Ashkenazi O
Jews O
both O
in O
familial B
breast I
and I
ovarian I
cancer I
and O
in O
the O
general O
population O
. O

Hemochromatosis B
, O
the O
inherited B
disorder I
of I
iron I
metabolism I
, O
leads O
, O
if O
untreated O
, O
to O
progressive O
iron B
overload I
and O
premature B
death I
. O

W474C O
amino O
acid O
substitution O
affects O
early O
processing O
of O
the O
alpha O
- O
subunit O
of O
beta O
- O
hexosaminidase O
A O
and O
is O
associated O
with O
subacute O
G B
( I
M2 I
) I
gangliosidosis I
. O

We O
identified O
a O
1422 O
G O
- O
- O
> O
C O
( O
amino O
acid O
W474C O
) O
substitution O
in O
the O
first O
position O
of O
exon O
13 O
of O
HEXA O
of O
a O
non O
- O
Jewish O
proband O
who O
manifested O
a O
subacute O
variant O
of O
G B
( I
M2 I
) I
gangliosidosis I
. O

Insertional O
mutation O
by O
transposable O
element O
, O
L1 O
, O
in O
the O
DMD B
gene O
results O
in O
X B
- I
linked I
dilated I
cardiomyopathy I
. O

X B
- I
linked I
dilated I
cardiomyopathy I
( O
XLDCM B
) O
is O
a O
clinical O
phenotype O
of O
dystrophinopathy B
which O
is O
characterized O
by O
preferential O
myocardial B
involvement I
without O
any O
overt O
clinical O
signs O
of O
skeletal B
myopathy I
. O

Patients O
reported O
as O
having O
either O
neonatal O
SJS B
or O
SWS B
presented O
a O
combination O
of O
a O
severe O
, O
prenatal O
- O
onset O
neuromuscular B
disorder I
( O
with O
congenital B
joint I
contractures I
, O
respiratory O
and O
feeding O
difficulties O
, O
tendency O
to O
hyperthermia B
, O
and O
frequent O
death O
in O
infancy O
) O
with O
a O
distinct O
campomelic B
- I
metaphyseal I
skeletal I
dysplasia I
. O

Oral O
contraceptives O
protect O
against O
ovarian B
cancer I
in O
general O
, O
but O
it O
is O
not O
known O
whether O
they O
also O
protect O
against O
hereditary B
forms I
of I
ovarian I
cancer I
. O

A O
gene O
encoding O
a O
novel O
transmembrane O
protein O
was O
identified O
by O
DNA O
sequence O
analysis O
within O
the O
insulin B
- I
dependent I
diabetes I
mellitus I
( O
IDDM B
) O
locus O
IDDM4 O
on O
chromosome O
11q13 O
. O

Four O
patients O
had O
a O
germ O
- O
line O
E1317Q O
missense O
variant O
of O
APC O
that O
was O
not O
present O
in O
controls O
; O
one O
of O
these O
individuals O
had O
an O
unusually O
large O
number O
of O
metaplastic B
polyps I
of I
the I
colorectum I
. O

Wolfram B
syndrome I
( O
WFS B
; O
OMIM O
222300 O
) O
is O
an O
autosomal B
recessive I
neurodegenerative I
disorder I
defined O
by O
young O
- O
onset O
non O
- O
immune O
insulin B
- I
dependent I
diabetes I
mellitus I
and O
progressive O
optic B
atrophy I
. O

Human B
complement I
factor I
H I
deficiency I
associated O
with O
hemolytic B
uremic I
syndrome I
. O

Mutations O
of O
the O
human O
PAX6 O
gene O
underlie O
aniridia B
( O
congenital B
absence I
of I
the I
iris I
) O
, O
a O
rare O
dominant O
malformation B
of I
the I
eye I
. O

Distribution O
of O
emerin O
and O
lamins O
in O
the O
heart O
and O
implications O
for O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
. O

Emerin O
is O
a O
nuclear O
membrane O
protein O
which O
is O
missing O
or O
defective O
in O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
( O
EDMD B
) O
. O

The O
ATP7B O
gene O
has O
been O
excluded O
in O
the O
much O
rarer O
human O
copper B
overload I
disease O
non B
- I
Indian I
childhood I
cirrhosis I
, O
indicating O
genetic O
heterogeneity O
. O

Localization O
of O
human O
BRCA1 O
and O
its O
loss O
in O
high O
- O
grade O
, O
non B
- I
inherited I
breast I
carcinomas I
. O

Although O
the O
link O
between O
the O
BRCA1 O
tumour B
- O
suppressor O
gene O
and O
hereditary B
breast I
and I
ovarian I
cancer I
is O
established O
, O
the O
role O
, O
if O
any O
, O
of O
BRCA1 O
in O
non B
- I
familial I
cancers I
is O
unclear O
. O

Immunohistochemical O
staining O
of O
human O
breast O
specimens O
also O
revealed O
BRCA1 O
nuclear O
foci O
in O
benign O
breast O
, O
invasive B
lobular I
cancers I
and O
low B
- I
grade I
ductal I
carcinomas I
. O

